Scott Emerson - Genomma Lab Independent Director
| LABB Stock | MXN 14.59 0.52 3.44% |
Director
Mr. Scott R. Emerson serves as Independent Director of Genomma Lab Internacional, S.A.B. de C.V. since April 15, 2015. He is the Founder and President of The Emerson Group and its subsidiaries, Healthcare and Emerson Emerson Marketing. He has over 30 years experience in management positions in the areas of brand management, development new business, sales operations and field sales in Fortune 500 companies, including Johnson Johnson, Unilever and Novartis Consumer Health. He also serves as Member of the Board of Consumer Health Products Association, National Association of Chain Drug. since 2015.
| Tenure | 9 years |
| Phone | 52 55 5081 0000 |
| Web | https://www.genommalab.com |
Genomma Lab Management Efficiency
The company has return on total asset (ROA) of 0.0921 % which means that it generated a profit of $0.0921 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1264 %, meaning that it generated $0.1264 on every $100 dollars invested by stockholders. Genomma Lab's management efficiency ratios could be used to measure how well Genomma Lab manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | DIRECTOR Age | ||
| Alberto Balderas | Grupo Financiero Banorte | N/A | |
| Jorge Franco | Kimberly Clark de Mxico | 69 | |
| Jesus Martinez | Gruma SAB de | 62 | |
| Javier Flores | Grupo Financiero Banorte | N/A | |
| Miguel Magnani | Grupo Financiero Banorte | 48 | |
| Rafael Garcia | Grupo Mxico SAB | N/A | |
| Homero Moreno | Gruma SAB de | 60 | |
| Alfredo Ayub | Grupo Financiero Banorte | 67 | |
| Jose Rodriguez | Kimberly Clark de Mxico | N/A | |
| Bernardo Paasch | Kimberly Clark de Mxico | N/A | |
| Miguel Neaves | Grupo Mxico SAB | N/A | |
| Jorge Martin | Grupo Financiero Banorte | N/A | |
| Juan Hierro | Grupo Financiero Banorte | N/A | |
| Alfonso Noriega | Grupo Financiero Banorte | 57 | |
| Carmen Guerra | Grupo Financiero Banorte | 62 | |
| Carlos Curiel | Kimberly Clark de Mxico | N/A | |
| Alberto Lopez | Grupo Financiero Banorte | 51 | |
| David Montemayor | Grupo Financiero Banorte | 69 | |
| Jorge Robles | Grupo Financiero Banorte | N/A | |
| Ricardo Sebastian | Grupo Financiero Banorte | N/A | |
| Alejandro Morales | Grupo Financiero Banorte | N/A | |
Management Performance
| Return On Equity | 0.13 | |||
| Return On Asset | 0.0921 |
Genomma Lab Internacional Leadership Team
Elected by the shareholders, the Genomma Lab's board of directors comprises two types of representatives: Genomma Lab inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Genomma. The board's role is to monitor Genomma Lab's management team and ensure that shareholders' interests are well served. Genomma Lab's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Genomma Lab's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Maximo Juda, CEO, COO and Executive Vice-Pres | ||
| Scott Emerson, Independent Director | ||
| Stefano Curti, Global President of Brands | ||
| Cesar Lopez, Vice President of Global Marketing | ||
| Efran Crdova, Deputy Sec | ||
| Ramon Sastre, Executive Vice President of Institutional Relations | ||
| Carlos Alonso, Independent Director | ||
| Marianne Velasco, Global HR | ||
| Marco Munoz, Non-Member Secretary of the Board of Directors | ||
| Jorge Munoz, Independent Director | ||
| Ignacio Rodriguez, Independent Director | ||
| Alejandro Patino, Executive Vice President of Human Capital and Commercial Expansion | ||
| L Porres, Legal Officer | ||
| Leandro Gold, Independent Director | ||
| Jose Fernandez, Independent Director | ||
| Rodrigo Aspra, Chairman of the Board, Independent Director | ||
| Claudia Vettoretti, Vice-President of Marketing | ||
| Renata Aspra, COO and Executive Vice-Pres | ||
| Juan Gavito, Independent Director | ||
| Antonio Galland, Executive Vice President, Chief Financial and Chief Administrative Officer | ||
| Luis MacKissack, Director | ||
| Arturo Perez, Director | ||
| Hector Gonzalez, Independent Director | ||
| Burkhard Wittek, Director | ||
| Alejandro Patio, Media, Relations | ||
| Marco Sparvieri, Executive Vice-President of Global Sales | ||
| Javier Castilla, Independent Director | ||
| Engineer Galland, Exec CFO | ||
| Sabrina Aspra, Director of International Operations, Director | ||
| Mximo Juda, Advisor | ||
| Daniel Neria, Head Relations | ||
| Juan Alonso, Independent Director | ||
| Santiago Pelaez, Vice President of Industrial and Research and Development | ||
| Jorge Valderrama, Chief Executive Officer | ||
| Juan Sparvieri, Chief Operating Officer, Vice President | ||
| Roberto Sauma, Independent Director | ||
| Leticia Herrera, Global Director of Human Resources (Genomma Experience) |
Genomma Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Genomma Lab a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.13 | |||
| Return On Asset | 0.0921 | |||
| Profit Margin | 0.08 % | |||
| Operating Margin | 0.20 % | |||
| Current Valuation | 20.43 B | |||
| Shares Outstanding | 1 B | |||
| Shares Owned By Insiders | 29.00 % | |||
| Shares Owned By Institutions | 29.10 % | |||
| Price To Earning | 13.61 X | |||
| Price To Book | 1.51 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Genomma Lab Internacional. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Complementary Tools for Genomma Stock analysis
When running Genomma Lab's price analysis, check to measure Genomma Lab's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Genomma Lab is operating at the current time. Most of Genomma Lab's value examination focuses on studying past and present price action to predict the probability of Genomma Lab's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Genomma Lab's price. Additionally, you may evaluate how the addition of Genomma Lab to your portfolios can decrease your overall portfolio volatility.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |